Skip to content

Strokecopilot: A Precision Medicine Tool in the Stroke Emergency

Strokecopilot: A Precision Medicine Tool in the Stroke Emergency

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05534295
Acronym
Strokecopilot
Enrollment
10000
Registered
2022-09-09
Start date
2022-05-10
Completion date
2023-12-31
Last updated
2023-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebrovascular Accident (CVA)

Keywords

cerebrovascular accident (CVA), Ischemic stroke, thrombolysis channels, intravenous thrombolysis, mechanical thrombectomy

Brief summary

Ischemic stroke or cerebral infarction (CI) is an immediate emergency affecting approximately 100,000 - 150,000 patients each year in France and is managed in the neurovascular intensive care unit (NICU). Recanalization treatments can prevent disability, but patients must be carefully selected. Knowledge in this field is evolving rapidly, which tends to make management more complex and personalized. In addition, the permanence of thrombolysis channels involves neurologists of all expertise. Decision support tools are desirable to enable precision medicine in stroke. Strokecopilot is a web application developed by the principal investigator. Its algorithm contextualizes the patient in a set of evidence-based medicine references (recommendations and clinical trials) and gives the result of their cross-referencing to the user to indicate theoretical indications for intravenous thrombolysis and mechanical thrombectomy.

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\- Adult patient (\>18 years old) admitted to the thrombolysis unit of the University Hospital of Strasbourg from January 01, 2017 to December 31, 2021

Exclusion criteria

\- Subjects who have expressed their opposition to the use of their data for scientific research purposes.

Design outcomes

Primary

MeasureTime frame
Retrospective analysis of thrombolysis data for the development of an algorithm to detect thrombolysisFiles analysed retrospectively from January 01, 2017 to December 31, 2021 will be examined

Countries

France

Contacts

Primary ContactValérie WOLFF, MD, PhD
valerie.wolff@chru-strasbourg.fr33 3 88 12 85 19

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026